New pacing technique aims to prevent heart failure in High-Risk HCM patients
NCT ID NCT07372196
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new pacing method (left bundle branch pacing) with a standard pacemaker-defibrillator in 30 people who have hypertrophic cardiomyopathy and a specific heart block after myectomy surgery. The goal is to see if the new method better prevents heart failure worsening and dangerous heart rhythms. Participants will be randomly assigned to one of the two devices and followed for 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCM - HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Meshalkin Scientific Research Center of the Ministry of Health of Russia
RECRUITINGNovosibirsk, Novosibirsk Oblast, 630055, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may catch hidden heart failure before It's too late
- Heart shock test during ICD implant may leave no trace, study suggests
- Heart device data may unlock secrets of rare heart muscle disease
- New sensor aims to predict heart failure readmissions without needles
- Shock therapy: can a heart device save lives in rare angina?
- Tiny heart monitor could uncover why dialysis patients die suddenly